[HTML][HTML] Diagnosis and subclassification of acute lymphoblastic leukemia
S Chiaretti, G Zini, R Bassan - Mediterranean journal of …, 2014 - ncbi.nlm.nih.gov
Acute lymphoblastic leukemia (ALL) is a disseminated malignancy of B-or T-lymphoblasts
which imposes a rapid and accurate diagnostic process to support an optimal risk-oriented …
which imposes a rapid and accurate diagnostic process to support an optimal risk-oriented …
Adult acute lymphoblastic leukaemia
R Bassan, G Gatta, C Tondini, R Willemze - Critical reviews in oncology …, 2004 - Elsevier
Acute lymphoblastic leukaemia (ALL) in adults is a relatively rare neoplasm with a curability
rate around 30% at 5 years. This consideration makes it imperative to dissect further the …
rate around 30% at 5 years. This consideration makes it imperative to dissect further the …
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida… - Leukemia, 2012 - nature.com
Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on
expert opinions, but they have not been validated. Here we present the validated EuroFlow …
expert opinions, but they have not been validated. Here we present the validated EuroFlow …
[HTML][HTML] Expression of aberrant antigens in hematological malignancies: A single center experience
A Shahni, M Saud, S Siddiqui… - Pakistan journal of …, 2018 - ncbi.nlm.nih.gov
Methods: One milliliter peripheral blood or bone marrow samples were analyzed on FACS
Calibur flowcytometer. The cells were lysed and stained following standard protocol. Data …
Calibur flowcytometer. The cells were lysed and stained following standard protocol. Data …
Re-expression of poly/oligo-sialylated adhesion molecules on the surface of tumor cells disrupts their interaction with immune-effector cells and contributes to …
Simple Summary The immune system consists of various mechanisms contributing to the
battle against cancer cells or hazardous pathogens. However, in cancer progression the …
battle against cancer cells or hazardous pathogens. However, in cancer progression the …
Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia
NAB Abdulateef, MM Ismail… - Asian Pacific Journal of …, 2014 - koreascience.kr
Background: Aberrant phenotypes in acute leukemia have variable frequency and their
prognostic and predictive relevance is controversial, despite several reports of clinical …
prognostic and predictive relevance is controversial, despite several reports of clinical …
Aberrant T‐cell antigen expression in B lymphoblastic leukaemia
S Hussein, KZ Gill, AN Sireci, AI Colovai… - British journal of …, 2011 - Wiley Online Library
Summary B lymphoblastic leukaemia (B‐ALL) cells are characterized by the expression of
various B‐cell antigens. Expression of T/Natural Killer‐cell antigens, however, has rarely …
various B‐cell antigens. Expression of T/Natural Killer‐cell antigens, however, has rarely …
[HTML][HTML] Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
OK Weinberg, KM Chisholm, CY Ok, Y Fedoriw… - Modern Pathology, 2021 - Elsevier
Natural killer (NK) cells are lymphocytes of the native immune system that play a pivotal role
in host defense and immune surveillance. While the conceptual view of NK-neoplasms is …
in host defense and immune surveillance. While the conceptual view of NK-neoplasms is …
Expression of CD56 defines a distinct subgroup in childhood T‐ALL with inferior outcome. Results of the ALL‐BFM 2000 trial
S Fuhrmann, R Schabath, A Möricke… - British Journal of …, 2018 - Wiley Online Library
This study reports the prognostic impact of the expression of the natural killer cell marker CD
56 in a large series of risk‐adapted paediatric patients with T cell acute lymphoblastic …
56 in a large series of risk‐adapted paediatric patients with T cell acute lymphoblastic …
[HTML][HTML] CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival …
L Fischer, N Gökbuget, S Schwartz, T Burmeister… - …, 2009 - ncbi.nlm.nih.gov
CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic
phenotype and resistance to induction therapy but no inferior survival after risk-adapted …
phenotype and resistance to induction therapy but no inferior survival after risk-adapted …